Fenoldopamin in cardiac surgery;Fenoldopamin in der Herzchirurgie

Clinical Research in Cardiology Supplements

Volumn 2, Issue SUPL.1, 2007, Pages

  Landoni, G ^a,b   Poli, D ^a,b   Bove, T ^a,b  

^a VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

^b SAN RAFFAELE HOSPITAL   (Italy)

Author keywords

acute renal failure; cardiac surgery; diuretics; fenoldopam; renal replacement therapy

Indexed keywords

EID: 74949121963     PISSN: 18610706     EISSN: 18610714     Source Type: Journal    
DOI: 10.1007/s11789-006-0046-5     Document Type: Review

References (41)

1. Bhat JG, Gluck MC, Lowenstein J, Baldwin DS (1976) Renal failure after open heart surgery. Ann Intern Med 84:677-682
2. Biancofiore G, Della Rocca G, Bindi I et al (2004) Use of fenoldopam to control renal dysfunction early after liver transplantation. Liver Transpl 10:986-992
3. Bove T, Landoni G, Calabro MG et al (2005) Renoprotective action of fenoldopam in high-risk patients undergoing cardiac surgery: a prospective, double-blind, randomized clinical trial. Circulation 111:3230-3235
4. Brienza N, Malcangi V, Dalfino L et al (2006) A comparison between fenoldopam and low dose dopamine in early renal dysfunction of critically ill patients. Crit Care Med 34:707-714
5. Brienza N, Malcangi V, Faconda G et al (2003) Effects of fenoldopam in early renal dysfunction (ERD) in critically ill patients with chronic hypertension. Minerva Anestesiologica 69(suppl 2):A326
6. Caimmi PP, Pagani L, Micalizzi E et al (2003) Fenoldopam for renal protection in patients undergoing cardiopulmonary bypass. J Cardiothorac Vasc Anesth 17:491-494
7. Chertow GM, Levy EM, Hammermeister KE, Grover F, Daley JA (1998) Independent association between acute renal failure and mortality following cardiac surgery. Am J Med 104:343-348
8. Corwin HL, Sprague SM, DeLaria GA, Norusis MJ (1989) Acute renal failure associated with cardiac operations. A case-control study. J Thorac Cardiovasc Surg 98:1107-1112
9. Della Rocca G, Pompei L, Costa MG et al (2004) Fenoldopam mesylate and renal function in patients undergoing liver transplantation: a randomized, controlled pilot trial. Anesth Analg 99:1604-1609
10. Della Rocca G, Pompei L, Monaco S et al (2002) Renal protection and liver transplantation. Anesthesiology 96:A415
11. Doggrell SA (2002) The therapeutic potential of dopamine modulators on the cardiovascular and renal systems. Expert Opin Investig Drugs 11:631-644
12. Elliott WJ, Weber RR, Nelson KS, Oliner CM, Fumo Mt, Gretler DD (1990) Renal and hemodynamic effects of intravenous fenoldopam versus nitroprusside in severe hypertension. Circulation 81:970-997
13. Gailiunas P, Chawla R, Lazarus JM, Cohn L, Sanders J, Merrill JP (1980) Acute renal failure following cardiac operations. J Thorac Cardiovasc Surg 79:241-243
14. Garwood S, Davis E, Hines RL (1997) Fenoldopam: aneffective renal preservation agent in cardiac surgery? Anesthesiology 91:A154
15. Gastaldo P, Launo C (2004) Funzionalità renale durante anestesia generale in chirurgia aortica Minerva Anestesiologica 70 (suppl 2):A42-45
16. Gombotz H, Plaza J, Mahla E, Berger J, Metzler H (1998) DA1-receptor stimulation by fenoldopam in the treatment of postcardiac surgical hypertension. Acta Anaesthesiol Scand 42: 834-840
17. Halpenny M, Lakshmi S, O'Donnell A, O'Callaghan-Enright S, O'Connell D, Shorten G (2001) The effects of fenoldopam on coronary conduit blood flow after coronary artery bypass graft surgery. J Cardiothorac Vasc Anesth 15:72-76
18. Halpenny M, Lakshmi S, O'Donnell A, O'Callaghan-Enright S, Shorten G (2001) Fenoldopam: renal and splanchnic effects in patients undergoing coronary artery bypass grafting. Anaesthesia 56:953-960
19. Halpenny M, Rushe C, Breen P, Cunningham AJ, Boucher-Hayes D, Shorten GD (2002) The effects of fenoldopam on renal function in patients undergoing elective aortic surgery. Eur J Anaesthesiol 19:32-39
20. Hill A J, Feneck RO, Walesby RK (1993) A comparison of fenoldopam and nitroprusside in the control of hypertension following coronary artery surgery. J Cardiothorac Vasc Anesth 7:279-284
21. Kaplan JA, Reich DL, Konstadt SN (1999) Cardiac Anesthesia Fourth Edition. WB Saunders Co, Philadelphia, PA, pp 1074-1075
22. Kini AS, Mitre CA, Kamran M, Suleman J, Kim M, Duffy ME (2002) Changing trends in incidence and predictors of radiographic contrast nephropathy after percutaneous coronary intervention with use of fenoldopam. Am J Cardiol 89:999-1002
23. Madyoon H, Croushore L, Weaver D, Mathur V (2001) Use of fenoldopam to prevent radiocontrast nephropathy in high-risk patients. Catheter Cardiovasc Interv 53:341-345
24. Malcangi V, Dalfino L, Perchiazzi G, Di Venosa C, Pugliese V, Brienza N (2004) Disfunzione renale da shock: effetto nefroprotettivo del fenoldopam. Minerva Anestesiologica 70 (suppl 2):A361
25. Mangano CM, Diamondstone LS, Ramsay JG, Aggarwal A, Herskowitz A, Mangano DT (1998) Renal dysfunction after myocardial revascularization: risk factors, adverse outcomes, and hospital resource utilization. The multicenter study of perioperative ischemia research group. Ann Intern Med 128:194-203
26. McCune TR, Wombolt DG, Whelan TV, Thacker LR, Colonna JO (2005) Vasodilatation vs immunotherapy to prevent delayed graft function: delayed graft function as an indication of immune activation. Int Immunopharmacol 5:85-92
27. Morelli A, Ricci Z, Bellomo et al (2005) Prophylactic fenoldopam for renal protection in sepsis: a randomized, double-blind, placebo-controlled pilot trial. Crit Care Med 33: 2451-2456
28. Morelli A, Rocco M, Conti G et al (2004) Effects of short-term fenoldopam infusion on gastric mucosal blood flow in septic shock. Anesthesiology 101:576-582
29. Murphy MB, Murray C, Shorten GD (2001) Fenoldopam: a selective peripheral dopamine-receptor agonist for the treatment of severe hypertension. N Engl J Med 345:1548-1557
30. Pittarello D, Bonato R, Falasco G et al (2003) Studio degli effetti del fenoldopam in pazienti con lieve insufficienza renale sottoposti ad intervento chirurgico. Minerva Anestesiologica 69 (suppl 2):A162
31. Poinsot O, Romand JA, Favre H, Suter PM (1993) Fenoldopam improves renal hemodynamics impaired by positive end-expiratory pressure. Anesthesiology 79:680-684
32. Ranucci M, Soro G, Barzaghi N et al (2004) Fenoldopam prophylaxis of postoperative acute renal failure in high-risk cardiac surgery patients. Ann Thorac Surg 78:1332-1337
33. Renzini M, Fontanelli S, Manini E et al (2004) Fenoldopam in cardiochirurgia. Minerva Anestesiologica 70 (suppl 2): A269
34. Sheinbaum R, Ignacio C, Safi HJ, Estrera A (2003) Contemporary strategies to preserve renal function during cardiac and vascular surgery. Rev Cardiovasc Med 4 (suppl 1):S21-28
35. Sheinbaum R, Safi H, Ignacio C, Carter J, Reyna R (2000) Renal protection and improved outcome by utilization of a DA-1 agonist (fenoldopam) in TAAA repair. Anaesth Analg 90 (suppl:)SCA31
36. Shusterman NH, Elliott WJ, White WB (1993) Fenoldopam, but not nitroprusside, improves renal function in severely hypertensive patients with impaired renal function. Am J Med 95:161-168
37. Stone GW, McCullough PA, Tumlin JA, Lepor NE, Madyoon H, Murray P, Wang A, Chu AA, Schaer GL, Stevens M, Wilensky RL, O'Neill WW (2003) Fenoldopam mesylate for the prevention of contrast-induced nephropathy: a randomized controlled trial. JAMA 290:2284-2291
38. Taylor AA, Shepherd AM, Polvino W, et al (1999) Prolonged fenoldopam infusions in patients with mild to moderate hypertension: pharmacodynamic and pharmacokinetic effects. Am J Hypertens 12:906-914
39. Tumlin JA, Finkel KW, Murray PT, Samuels J, Cotsonis G, Shaw AD (2005) Fenoldopam mesylate in early acute tubular necrosis: a randomized, double-blind, placebo-controlled clinical trial. Am J Kidney Dis 46:26-34
40. Weber RR, McCoy CE, Ziemniak JA, Frederickson ED, Goldberg LI, Murphy MB (1988) Pharmacokinetic and pharmacodynamic properties of intravenous fenoldopam, a dopamine1-receptor agonist, in hypertensive patients. Br J Clin Pharmacol 25:17-21
41. White WB, Halley SE (1989) Comparative renal effects of intravenous administration of fenoldopam mesylate and sodium nitroprusside in patients with severe hypertension. Arch Intern Med 149:870-874